Home

Thermo Fisher Scientific (TMO)

516.57
-7.07 (-1.35%)

Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows

The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide.

SummaryNewsPress ReleasesChartHistoricalFAQ
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSERVTY) and the best and worst performers in the research tools & consumables industry.
Via StockStory · March 3, 2025
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favorbenzinga.com
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.
Via Benzinga · February 25, 2025
Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billionbenzinga.com
Thermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth.
Via Benzinga · February 25, 2025
Thermo Fisher Scientific Unusual Options Activitybenzinga.com
Via Benzinga · February 21, 2025
Looking Into Thermo Fisher Scientific's Recent Short Interestbenzinga.com
Via Benzinga · February 20, 2025
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · February 3, 2025
Analyst Expectations For Thermo Fisher Scientific's Futurebenzinga.com
Via Benzinga · January 31, 2025
Smart Money Is Betting Big In TMO Optionsbenzinga.com
Via Benzinga · January 29, 2025
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Yearsbenzinga.com
Via Benzinga · February 18, 2025
3 Healthcare Stocks Skating on Thin Ice
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 12.8% climb.
Via StockStory · February 12, 2025
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · February 10, 2025
Gapping S&P500 stocks in Monday's sessionchartmill.com
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via Chartmill · February 10, 2025
Thermo Fisher Scientific Unusual Options Activity For January 21benzinga.com
Via Benzinga · January 21, 2025
Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcriptfool.com
TMO earnings call for the period ending December 31, 2024.
Via The Motley Fool · January 30, 2025
Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates
Life sciences company Thermo Fisher (NYSETMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per share was 2.7% above analysts’ consensus estimates.
Via StockStory · January 30, 2025
Top S&P500 movers in Thursday's sessionchartmill.com
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via Chartmill · January 30, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · January 30, 2025
Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beatinvestors.com
Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts.
Via Investor's Business Daily · January 30, 2025
Thursday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.
Via Chartmill · January 30, 2025
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expandsbenzinga.com
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.
Via Benzinga · January 30, 2025
9 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · January 28, 2025
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Massmarkets/com
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).
Via Benzinga · January 26, 2025
Earnings Scheduled For January 30, 2025benzinga.com
Via Benzinga · January 30, 2025
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recoverybenzinga.com
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.
Via Benzinga · January 24, 2025
Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.
Via MarketBeat · January 24, 2025